Affimed Long Term Debt 2014-2024 | AFMDQ
Affimed long term debt from 2014 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Affimed Annual Long Term Debt
(Millions of US $) |
| 2023 |
$7 |
| 2022 |
$12 |
| 2021 |
$20 |
| 2020 |
$0 |
| 2019 |
$0 |
| 2018 |
$2 |
| 2017 |
$5 |
| 2016 |
$4 |
| 2015 |
$3 |
| 2014 |
$5 |
| 2013 |
$0 |
| 2012 |
$0 |
Affimed Quarterly Long Term Debt
(Millions of US $) |
| 2024-09-30 |
$2 |
| 2024-06-30 |
$4 |
| 2024-03-31 |
$5 |
| 2023-12-31 |
$7 |
| 2023-09-30 |
$8 |
| 2023-06-30 |
$10 |
| 2023-03-31 |
$11 |
| 2022-12-31 |
$12 |
| 2022-09-30 |
$13 |
| 2022-06-30 |
$15 |
| 2022-03-31 |
$18 |
| 2021-12-31 |
$20 |
| 2021-09-30 |
$12 |
| 2021-06-30 |
$12 |
| 2021-03-31 |
$12 |
| 2020-12-31 |
$0 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$0 |
| 2019-09-30 |
$0 |
| 2019-06-30 |
$0 |
| 2019-03-31 |
$1 |
| 2018-12-31 |
$2 |
| 2018-09-30 |
$3 |
| 2018-06-30 |
$3 |
| 2018-03-31 |
$4 |
| 2017-12-31 |
$5 |
| 2017-09-30 |
$6 |
| 2017-06-30 |
$6 |
| 2017-03-31 |
$4 |
| 2016-12-31 |
$4 |
| 2016-09-30 |
$2 |
| 2016-06-30 |
$2 |
| 2016-03-31 |
$3 |
| 2015-12-31 |
$3 |
| 2015-09-30 |
$4 |
| 2015-06-30 |
$5 |
| 2015-03-31 |
$5 |
| 2014-12-31 |
$5 |
| 2014-09-30 |
$5 |
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-09-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.009B |
|
Affimed N.V is a clinical stage biopharmaceutical company. It is engaged in developing single and combination therapies to treat cancers. The company's product pipeline consists of AFM13, AFM24, AFM26, AFM11 and AMV564 which are in clinical stage. Affimed N.V, formerly known as Affimed Therapeutics B.V., is based in Heidelberg, Germany.
|
